|1.||Papadopoulos, Apostolos: 1 article (10/2009)|
|2.||Paravatou-Petsotas, Maria: 1 article (10/2009)|
|3.||Livaniou, Evangelia: 1 article (10/2009)|
|4.||Pietzsch, Hans-Jurgen: 1 article (10/2009)|
|5.||Pirmettis, Ioannis: 1 article (10/2009)|
|6.||Pelecanou, Maria: 1 article (10/2009)|
|7.||Bourkoula, Athanasia: 1 article (10/2009)|
|8.||Papadopoulos, Minas: 1 article (10/2009)|
|9.||Santos, Isabel: 1 article (10/2009)|
|10.||Richardson, Des R: 1 article (04/2003)|
01/01/1995 - "Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo."
10/01/2009 - "Aiming at the development of technetium-99m ((99m)Tc) complexes for early detection and staging of EGFR positive tumors, the tyrosine kinase inhibitor 6-amino-4-[(3-bromophenyl)amino]quinazoline was derivatized with pyridine-2-carboxaldehyde to generate the imine 6-(pyridine-2-methylimine)-4-[(3-bromophenyl)amino]quinazoline suitable for reacting with the fac-[(99m)Tc(CO)(3)](+) core as an N,N bidentate ligand. "
10/02/1992 - "Various substituted pyridine-2-carboxaldehyde thiosemicarbazones (12 compounds) have been synthesized and evaluated for antineoplastic activity in mice bearing the L1210 leukemia. "
01/01/1995 - "The synthesis of a new series of pyridine-2-carboxaldehyde thiosemicarbazones (HCTs) that have amino groups in the 3- and 5-positions has allowed the comparison of the structure/function relationships with regard to inhibition of ribonucleotide reductase activity, L1210 cell growth in culture and L1210 leukemia in vivo. "
|4.||Colonic Neoplasms (Colon Cancer)
|2.||Ribonucleotide Reductases (Ribonucleotide Reductase)
|3.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|5.||DNA (Deoxyribonucleic Acid)